Direkt zum Inhalt
Merck

Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair.

Science advances (2023-05-10)
Dinh Duc Nguyen, Eugene Kim, Nhat Thong Le, Xianzhong Ding, Rishi Kumar Jaiswal, Raymond Joseph Kostlan, Thi Ngoc Thanh Nguyen, Olga Shiva, Minh Thong Le, Weihang Chai
ZUSAMMENFASSUNG

Despite the high lethality of colorectal cancers (CRCs), only a limited number of genetic risk factors are identified. The mammalian ssDNA-binding protein complex CTC1-STN1-TEN1 protects genome stability, yet its role in tumorigenesis is unknown. Here, we show that attenuated CTC1/STN1 expression is common in CRCs. We generated an inducible STN1 knockout mouse model and found that STN1 deficiency in young adult mice increased CRC incidence, tumor size, and tumor load. CRC tumors exhibited enhanced proliferation, reduced apoptosis, and elevated DNA damage and replication stress. We found that STN1 deficiency down-regulated multiple DNA glycosylases, resulting in defective base excision repair (BER) and accumulation of oxidative damage. Collectively, this study identifies STN1 deficiency as a risk factor for CRC and implicates the previously unknown STN1-BER axis in protecting colon tissues from oxidative damage, therefore providing insights into the CRC tumor-suppressing mechanism.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-β-Actin-Antikörper, Maus monoklonal, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-OBFC1 antibody produced in mouse, clone 3G12-1B7, purified immunoglobulin, buffered aqueous solution